CoChat

Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial

Open access
the Ifigenia study group*, Behr, Jürgen, Demedts, Maurits, Buhl, Roland, Costabel, Ulrich, Dekhuijzen, Richard PN, Jansen, Henk M, MacNee, William, Thomeer, Michiel, Wallaert, Benoit, Laurent, Francois, Nicholson, Andrew G, Verbeken, Eric K, Verschakelen, Johny, Flower, CDR, Petruzzelli, Stefano, De Vuyst, Paul, Bosch, van den JMM, Rodriguez-Becerra, Eulogio, Lankhorst, Ida, Sardina, Marco, Boissard, Gabrielle · 2009 · Respiratory Research
Cited by 94

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The randomized placebo-controlled IFIGENIA-trial demonstrated that therapy with high-dose N-acetylcysteine (NAC) given for one year, added to prednisone and azathioprine, significantly ameliorates (i.e. slows down) disease progression in terms of vital capacity (VC) (+9%) and diffusing capacity (DLco) (+24%) in idiopathic pulmonary fibrosis (IPF). To better understand the clinical implications of these findings we performed additional, explorative analyses of the IFGENIA data set. METHODS: We analysed effects of NAC on VC, DLco, a composite physiologic index (CPI), and mortality in the 155 study-patients. RESULTS: In trial completers the functional indices did not change significantly with NAC, whereas most indices deteriorated with placebo; in non-completers the majority of indices worsened but decline was generally less pronounced in most indices with NAC than with placebo. Most categorical analyses of VC, DLco and CPI also showed favourable changes with NAC. The effects of NAC on VC, DLco and CPI were significantly better if the baseline CPI was 50 points or lower. CONCLUSION: This descriptive analysis confirms and extends the favourable effects of NAC on lung function in IPF and emphasizes the usefulness of VC, DLco, and the CPI for the evaluation of a therapeutic effect. Most importantly, less progressed disease as indicated by a CPI of 50 points or lower at baseline was more responsive to therapy in this study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1465-9921-10-101

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 94

Metadata

Authors
the Ifigenia study group*, Behr, J., Demedts, M., Buhl, R., Costabel, U., Dekhuijzen, R. P., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., Nicholson, A. G., Verbeken, E. K., Verschakelen, J., Flower, C., Petruzzelli, S., De Vuyst, P., Bosch, V. D. J., Rodriguez-Becerra, E., Lankhorst, I., Sardina, M., & Boissard, G.
Venue
Respiratory Research
Published
2009-10-27
Volume
10
Issue
1
Pages
101-101
ISSN
  • 1465-9921 (ISSN-L)
  • 1465-993X
OpenAlex
W2131944618
Cited by
94
References
9
FWCI
7.37
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial. https://app.cochat.ai/papers/10.1186/1465-9921-10-101
The paper
the Ifigenia study group*, Behr, J., Demedts, M., Buhl, R., Costabel, U., Dekhuijzen, R. P., Jansen, H. M., MacNee, W., Thomeer, M., Wallaert, B., Laurent, F., Nicholson, A. G., Verbeken, E. K., Verschakelen, J., Flower, C., Petruzzelli, S., De Vuyst, P., Bosch, V. D. J., Rodriguez-Becerra, E., . . . Boissard, G. (2009). Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial. Respiratory Research. https://doi.org/10.1186/1465-9921-10-101

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.